1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 4:Clinical associations of clival invasion
Operation Approaches Resection Extent Operative Complications Follow-Up Recurrence Transsphenoidal Transfrontal Gross Total Subtotal Cases Period (mo) Clival destruction 26/32 (81.25%) 6/32 (18.75%) 0 32 5/32 (15.63%) 14 6.78 ± 2.91 8/14 (57.14%) Without clival destruction 330/358 (92.18%) 28/358 (7.82%) 99 259 13/358 (3.63%) 56 8.58 ± 3.16 7/56 (12.50%) χ2 χ2 = 3.142, χ2 = 7.067 P < .001a χ2 = 10.739 P P = .076 P = 0.008 P = .001
a Two independent-samples t test.